- Home
- IGD vs AMLX Comparison
IGD vs AMLX Comparison
Compare IGD & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGD
- AMLX
- Stock Information
- Founded
- IGD N/A
- AMLX 2014
- Country
- IGD United States
- AMLX United States
- Employees
- IGD N/A
- AMLX N/A
- Industry
- IGD Trusts Except Educational Religious and Charitable
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- IGD Finance
- AMLX Health Care
- Exchange
- IGD Nasdaq
- AMLX Nasdaq
- Market Cap
- IGD 421.2M
- AMLX 481.9M
- IPO Year
- IGD N/A
- AMLX 2022
- Fundamental
- Price
- IGD $5.34
- AMLX $3.13
- Analyst Decision
- IGD
- AMLX Buy
- Analyst Count
- IGD 0
- AMLX 7
- Target Price
- IGD N/A
- AMLX $7.60
- AVG Volume (30 Days)
- IGD 215.3K
- AMLX 733.0K
- Earning Date
- IGD 01-01-0001
- AMLX 02-20-2025
- Dividend Yield
- IGD 9.15%
- AMLX N/A
- EPS Growth
- IGD N/A
- AMLX N/A
- EPS
- IGD N/A
- AMLX N/A
- Revenue
- IGD N/A
- AMLX $196,485,000.00
- Revenue This Year
- IGD N/A
- AMLX N/A
- Revenue Next Year
- IGD N/A
- AMLX N/A
- P/E Ratio
- IGD N/A
- AMLX N/A
- Revenue Growth
- IGD N/A
- AMLX N/A
- 52 Week Low
- IGD $4.60
- AMLX $1.58
- 52 Week High
- IGD $5.26
- AMLX $19.95
- Technical
- Relative Strength Index (RSI)
- IGD 41.61
- AMLX 27.41
- Support Level
- IGD $5.25
- AMLX $3.71
- Resistance Level
- IGD $5.48
- AMLX $4.18
- Average True Range (ATR)
- IGD 0.06
- AMLX 0.24
- MACD
- IGD -0.01
- AMLX -0.05
- Stochastic Oscillator
- IGD 30.36
- AMLX 9.48
About IGD Voya Global Equity Dividend and Premium Opportunity Fund
Voya Global Equity Dividend and Premium Opportunity Fund are a United States-based diversified, closed-end Fund. The primary objective of the Fund is to seek to provide investors with a high level of income from a portfolio of common stocks with historically attractive dividend yields and premiums from call option writing. The secondary investment objective of the company is capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its managed assets in a portfolio of common stocks of dividend-paying companies located throughout the world.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.